-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

627.P1.109 627. Aggressive Lymphomas: Clinical and Epidemiological: Poster I

Symposia: Aggressive Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Thomas A. Ollila, MD1, Rashida Taher, PA2*, Stephen Grado, MD3* and Adam J. Olszewski, MD4

1Lifespan Cancer Institute, Brown University, Providence, RI
2Lifespan Cancer Institute, Providence, RI
3Brown Alpert School of Medicine, Providence, RI
4Division of Hematology/Oncology, Brown University, Providence, RI

Prokop Vodicka1*, Katerina Benesova, MD, CSc.2*, Andrea Janikova, assoc. prof., MD, PhD3*, David Belada, assoc. prof., MD, PhD4*, Heidi Mocikova, MD, Ph.D.5*, Jan Pirnos, MD6*, Vit Prochazka, Prof., MD, PhD7*, Juraj Duras, MD8*, Katerina Kopeckova, MD, PhD9*, Katerina Steinerova, MD10*, Petra Blahovcova, Mgr11*, Vit Campr, MD12*, Pavel Klener Jr., Prof., MD, PhD1*, Alice Sykorova, MD, PhD13* and Marek Trneny, MD14

1First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
21st Department Medicine, 1st Faculty of Medicine, Charles University, General Hospital, Prague, CZE
3Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
4Fourth Department of Internal Medicine – Hematology, Charles University and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
5Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE, Czech Republic
6Department of Oncology, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic
7Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
8Department of Hematology, Medical Faculty of the Ostrava University and University Hospital, Ostrava, Czech Republic
9Department of Oncology of the 2nd Faculty of Medicine of Charles University and University Hospital in Motol, Prague, Czech Republic
10Department of Haemato-Oncology, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czech Republic
11Data Centre, Czech Lymphoma Study Group, Prague, Czech Republic
12Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
13Fourth Department of Internal Medicine – Hematology, Faculty of Medicine, Charles University and University Hospital Hradec Kralove, Hradec Kralove, CZE
14First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic

Maegan Ford, MD, MPH1, Evelyn Orlando, MD2, Zhezhen Jin, PhD3*, Andrew H. Lipsky, MD4, Ahmed Sawas, MD5, Barbara Pro, MD5 and Jennifer E. Amengual, MD5

1Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
2Internal Medicine Residency Program, Columbia University Medical Center, New York, NY
3Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY
4Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
5Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

Star Ye, MD1, Christian Harmon, MD2*, Nadia Anabtawi, BS3*, Clare Ubersax, BS2*, Abigail Tucker, MSPH2*, Gaurav Goyal, MD1, Lauren Shea, MD1*, Mayur Narkhede, MBBS1, Amitkumar Mehta, MD1, Purnima Singh, PhD, MSc2, Grant Williams, MD, MPH1*, Smita Bhatia, MD, MPH2 and Smith Giri, MD, MHS2

1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
3Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL

Esther Bronwyn Ting1*, Sahar Khan, FRCPath, MD2*, Manjula Maganti, MSc3*, Sita Bhella, M.D., MSc4*, Michael Crump4, David C. Hodgson, MD, MPH, FRCPC5*, Robert Kridel, MD4, Vishal Kukreti, MD, FRCP, MSc4, John Kuruvilla, MD4, Danielle Rodin, MD, MPH5*, Richard Tsang, MD, FRCPC5* and Anca Prica, MD, MSc4

1Nepean Hospital, Nepean Blue Mountains Local Health District, Sydney, NSW, Australia
2Windsor Regional Cancer Centre, Windsor, ON, CAN
3Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
5Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Pere Barba, MD1*, Marta Ligero2*, Cecilia Carpio, MD3*, Maria Balaguer2*, Víctor Navarro Garcés4*, Sabela Bobillo, MD, PhD3*, Francisco Beas5*, Pau Abrisqueta, MD, PhD3*, Roser Sala2*, Francesc Bosch, MD, PhD6, Gloria Iacoboni, MD7*, Marc Simo, MD8* and Raquel Perez-Lopez2*

1Department of Hematology, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
2Radiomics Unit, Vall Hebron Institute of Oncology, Barcelona, Spain
3Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
4Vall Hebron Institute of Oncology, BARCELONA, Spain
5Vall Hebron Institute of Oncology, Barcelona, Spain
6Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
7Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
8Department of Nuclear Medicine. Vall D'Hebron University Hospital, Barcelona., Barcelona, ESP

Teresa Calimeri, MD, PhD1, Sara Steffanoni, MD1*, Alice Laurenge, MD2*, Christopher P. Fox3*, Carole Soussain, MD4*, Christian Grommes, MD5, Maria Chiara Tisi, MD6*, Jesca Boot, MD7*, Nicola Crosbie, MD8*, Carlo Visco, MD9*, Luca Arcaini, MD10*, Sridhar Chaganti, MD11*, Alvaro J. Alencar, MD12, Daniele Armiento, MD13*, Ilaria Romano, MD14*, Marianna C. Sassone, MD15*, Jorg Dietrich, MD PhD16*, Gilad Itchaki17*, Riccardo Bruna, MD18*, Nicola S Fracchiolla, MD19*, Laura Arletti, MD20*, Adriano Venditti, MD21, Stephen Booth, MD22*, Pellegrino Musto23, Khe Hoang-Xuan, MD, PhD2*, Tracy Batchelor, MD24, Kate Cwynarski, MD25* and Andrés José María J.M. Ferreri, MD15

1Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
2Service de Neurologie 2-Mazarin, Hôpitaux Universitaires La Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France
3Department of Hematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
4Hematologie, Hôpital René Huguenin-Institut Curie, Saint-Cloud, Paris, France
5Department of Medicine, Neuro-Oncology Service, Memorial Sloan Kettering Cancer, New York, NY
6Division of Hematology, Ospedale San Bortolo, Vicenza, Italy
7Barking, Havering and Redbridge University Hospitals NHS Trust, London, United Kingdom
8Derriford Hospital, Plymouth, United Kingdom
9University of Verona, Verona, ITA
10Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy
11Department of Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
12Miller School of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
13Division of Hematology, Campus Bio Medico, Roma, Italy
14Division of Hematology, Ospedale Careggi, Firenze, Italy
15Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
16Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA
17Institute of Hematology,, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
18Division of Hematology, Ospedale Maggiore, Novara, Italy
19Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, MILANO, Italy
20Division of Hematology,, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy
21Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
22NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, ENG, United Kingdom
23Department of Emergency and Organ Transplantation, "Aldo Moro" University School of Medicine and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy
24Department of Neurology, Brigham and Women's Hospital, Boston, MA
25University College London Hospitals NHS Foundation Trust, London, United Kingdom

Mirian Brink, PhD1*, Arie C. van der Spek, MD, MSc2*, Koen de Heer, MD, PhD3*, Sabina Kersting, MD, PhD4*, Lidwine W. Tick, MD, PhD5, Hanneke M. van der Straaten, MD, PhD6*, Rogier Mous7*, Mark-David Levin8, Doreen te Raa, MD, PhD9*, Michel van Gelder10, Jeanette K. Doorduijn, MD, PhD11, Arnon P. Kater, MD, PhD12, Gerwin Huls, MD PhD13* and Mar Bellido, MD, PhD14*

1Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands, Utrecht, Netherlands
2Department of Internal Medicine, North-West Hospital, Alkmaar, Netherlands
3Department of Internal Medicine, Flevo Hospital, Almere, Netherlands
4Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
5Maxima Medical Center, Veldhoven, NLD
6Department of Internal Medicine, St. Jansdal Hospital, Harderwijk, Netherlands
7UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, Netherlands
8Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, Netherlands
9Department of Hematology, Hospital Gelderse Vallei, Ede, Netherlands
10Dept internal medicine, Maastricht University Medical Center, Maastricht, Netherlands
11Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
12Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
13Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
14Department of Hematology, University Medical Center Groningen, Groningen, Netherlands

Guang-Liang Chen, MD1*, Pin Guo, MD, PhD2*, Shiyu Jiang, MD3*, Juan J. Gu, MD, PhD4,5,6, Qunling Zhang, MD, PhD3*, Yizhen Liu, MD, PhD3*, Junning Cao, MD3,7,8, Xiaonan Hong, MD9*, Rong TAO, PhD3,10* and Fangfang Lv3*

1Department of Lymphoma,, Fudan University Shanghai Cancer Center, Shanghai, China
2Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, China
3Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
4Roswell Park Cancer Institute, Buffalo, NY
5Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
7Fudan University Shanghai Cancer Center, Shanghai, China
8Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China
9Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
10Fudan University Shanghai Cancer Center, Shanghai, Shanghai, CHN

Daisuke Nakamura, MD, PhD*, Tomohisa Tabuchi, MD*, Naosuke Arima, MD*, Maiko Hayashida, MD*, Akihiko Arai, MD*, Makoto Yoshimitsu, MD, PhD and Kenji Ishitsuka, MD, PhD

Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan

Maegan Ford, MD, MPH1, Evelyn Orlando, MD2, Zhezhen Jin, PhD3*, Andrew H. Lipsky, MD4, Ahmed Sawas, MD5, Barbara Pro, MD5 and Jennifer E. Amengual, MD5

1Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
2Internal Medicine Residency Program, Columbia University Medical Center, New York, NY
3Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY
4Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
5Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

M. Christina Cox, MD, PhD1, Sabrina Pelliccia, MD2*, Paola Orlandi3*, Arianna Di Napoli4*, Gerardo Musuraca5*, Caterina Patti, MD6*, Maria Paola Bianchi7*, Matteo Caridi8*, Marta Banchi3*, Roberta Battistini, MD9*, Tiziana Lanzolla10*, Agostino Tafuri11 and Guido Bocci3*

1Hematology, Policlinico Tor Vergata, Rome, Italy
2Hematology, Sant’Andrea Hospital, Rome, Italy
3Pharmacology, University of Pisa, Pisa, Italy
4Pathology unit, Azienda Ospedaliera-Universitaria Sant'Andrea, Rome, Italy
5Division of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
6Division of Hematology, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
7Azienda Ospedaliera Sant'Andrea, Rome, Italy
8Hematology, University of Perugia, Perugia, Italy
9Hematology, San Camillo Hospital, Rome, Italy
10Nuclear Medicine, Azienda Ospedaliera-Universitaria Sant'Andrea, Rome, Italy
11University Hospital Sant'Andrea-Sapienza, Rome, Italy

Supreet Kaur, MD1, Qianqian Liu, PhD2*, Joel E Michalek, PhD2* and Adolfo Enrique Diaz Duque, MD3

1University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
2Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
3Hematology-Oncology Division, UT Health San Antonio / Mays Cancer Center, San Antonio, TX

Ranjit Nair, MD1, Amy Ayers, MPH2*, Loretta J. Nastoupil, MD2, Jillian R. Gunther, MD, PhD3*, Luis Fayad, MD2, Nathan H. Fowler, MD2, Roberto N. Miranda, MD4*, Fredrick B. Hagemeister, MD5, Hun Ju Lee, MD2, Maria Alma Rodriguez, MD6*, Raphael Steiner, MD2*, Paolo Strati, MD2, Yago Nieto, MD7, Jeremy L. Ramdial, MD8, Dai Chihara, MD2, Michael L. Wang, MD2, Luis E Malpica Castillo, MD9*, Neeraj Saini, MD8, Preetesh Jain, MBBS, MD, DM, PhD10, Chelsea C. Pinnix, MD, PhD3, Bouthaina S. Dabaja, MD3*, Michael R. Green, PhD11, Christopher R. Flowers, MD12, L. Jeffrey Medeiros, MD4, Mario L. Marques-Piubelli, MD13*, Francisco Vega, MD, PhD14, Mansoor Noorani15*, Sairah Ahmed, MD2, Jason Westin, MD16, Sattva S. Neelapu, MD2, Lei Feng, MS17* and Swaminathan Padmanabhan Iyer, MD2*

1Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston, TX
7Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
8Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma and Myeloma, UTMDACC, Houston, TX
11Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Friendswood, TX
12Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
13Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
14Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
15UTMDACC, Houston
16The University of Texas MD Anderson Cancer Center, Houston, TX
17Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Hedi Bensaber, MD1*, Emmanuel Bachy, MD, PhD2*, David Beauvais, MD3,4*, Remy Dulery5*, Thomas Gastinne, MD6*, Bruno Villemagne, MD7*, Louise Roulin8*, Etienne Paubelle, MD9*, Cristina Castilla-Llorente, MD10*, Thomas Longval, MD11*, Elodie Gat12*, Amandine Fayard, MD1*, Jacques-Olivier Bay, MD, PhD1, Steven Le Gouill, MD, PhD13*, Roch Houot, MD, PhD14* and Romain Guieze, MD, PhD1*

1Department of Hematology and Cell Therapy, Estaing University Hospital, CLERMONT-FERRAND, France
2Department of Hematology, Lyon-Sud Hospital, Pierre-Benite, France
3Hématologie clinique, CHU de Lille, Lille, France
4Department of Hematology, University Hospital of Lille, Lille, France
5Service d’Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
6Hematology Department, Nantes University Hospital, Nantes, France
7Clinical Hematology, Hospital of Vendée, La Roche-sur-Yon, France
8Hôpital Henri Mondor, Creteil, France
9Service d’Hématologie Clinique et Thérapie cellulaire, Centre Hospitalier Universitaire d’Amiens, Amiens, France
10Department of hematology, Gustave Roussy Institute, Villejuif, France
11Department of Hematology, Versailles Hospital, Le Chesnay-Rocquencourt, France
12LYSARC, The Lymphoma Academic Research Organisation, Lyon Sud Hospital, PIERRE-BENITE, France
13Curie Institute, Paris, France
14Department of Hematology, University Hospital of Rennes, Rennes, FRA

Peiqi Zhao1*, Lei Zhu1*, Lanfang Li1*, Shiyong Zhou2*, Lihua Qiu2*, Kai Fu3 and Huilai Zhang, M.D.1*

1Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
2Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
3Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE

Christian Grommes, MD1, Anna Piotrowski, MD2*, Elena Pentsova, MD2*, Igor Gavrilovic, MD3*, Jacqueline B Stone, MD3*, Andrew Lin, MD2*, Venissala Wongchai2*, Juli T Madzsar3*, Rachna Malani2*, Craig Nolan, MD2*, Jasmine Francis2*, Lisa DeAngelis, MD4*, Lauren Schaff, MD3* and Ingo K Mellinghoff, MD5*

1Department of Medicine, Neuro-Oncology Service, Memorial Sloan Kettering Cancer, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY
5Memorial Sloan-Kettering Cancer Center, New York, NY

Masahiro Akimoto, MD1*, Takuya Miyazaki, MD1*, Hiroyuki Takahashi, MD2*, Yusuke Saigusa, PhD3*, Takaaki Takeda, MD2*, Yuto Hibino, MD2*, Mayumi Tokunaga, MD2*, Takuma Ohashi, MD4*, Ayako Matsumura, MD1*, Haruka Teshigawara, MD4*, Taisei Suzuki, MD5*, Hiroshi Teranaka, MD4*, Yuki Nakajima, MD1*, Kenji Matsumoto, MD4*, Chizuko Hashimoto, MD6*, Katsumichi Fujimaki, MD, PhD5*, Hiroyuki Fujita, MD7, Rika Sakai2, Shin Fujisawa, MD1* and Hideaki Nakajima, MD4

1Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
2Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
3Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan
4Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
5Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan
6Department of Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan
7Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan

Anthea Peters, MD1, Grzegorz S. Nowakowski, MD2, Rosy Dabas, PhD3*, Theresa Amoloja, MPH4*, Zhenyi Xue, PhD4*, Caroline Koch, PhD3*, Eva E. Waltl, PhD5* and Isabelle Fleury, MD6

1Department of Oncology, University of Alberta, Edmonton, AB, Canada
2Division of Hematology, Mayo Clinic, Rochester, MN
3Incyte Biosciences Canada, Pointe-Claire, QC, Canada
4Incyte Corporation, Wilmington, DE
5MorphoSys AG, Planegg, Germany
6Maisonneuve-Rosemont Hospital, Montreal University, Montreal, QC, Canada

NA Zhang1* and Kai Hu, M.D., Ph.D.2*

1Beijing Boren Hospital, Beijing, AL, China
2Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China

Ofrat Beyar Katz1,2, Chava Perry, MD, PhD1,3*, Efrat Luttwak, MD1,3*, Inbal Sdayoor1*, Yael Bar-On, MD1,2*, Odelia Amit, MD1,2*, Ronit Gold2*, Yair Herishanu, MD1,3*, Noam Benyamini, MD1,3*, Sigal Grisariu Greenzaid, MD4,5*, Batia Avni6,7*, Polina Stepensky5,7*, Diana Libster, MD6,8, Dana Yehudai-Ofir, MD9,10*, Shimrit Harlev9,10*, Liat Sharvit10*, Tsila Zuckerman, MD9,10, Uri Greenbaum11*, Irit Avivi, MD1,3* and Ron Ram, MD1,2

1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Bone Marrow Transplant Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
3Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
5Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
6Department of Bone Marrow Transplantation & Cancer Immunotherapy Hadassah Medical Center Jerusalem, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
7Department of Bone Marrow Transplantation, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
8Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
9The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
10Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
11Soroka University Medical center, Beer Sheva, Israel

Michael Dickinson, MD1, Giuseppe Gritti2*, Carmelo Carlo-Stella, MD, PhD3, Harriet S Walter4*, David Carlile5*, Nicole Getzmann6*, Samira Curdt7*, Emma Harrop8*, Abiraj Keelara, PhD9*, Koorosh Korfi, PhD10*, Remi Labatut10*, Francesca Michielin10*, Sarah Louise Mycroft11*, Tom Moore, MD7*, Robert Nutbrown12*, Giuseppe Palldino13*, Matt Whayman11*, Johannes Sam, PhD14*, Martin Weisser, MD, PhD15*, Katharina E Lechner15*, Franck Morschhauser, MD, PhD16* and Martin Hutchings, MD, PhD17*

1Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
2Ematologia, ASST PAPA GIOVANNI XXIII, Bergamo, ITA
3Humanitas Clinical and Research Center, Humanitas University, Milan, Italy
4The HOPE Clinical Trials Unit, Leicester, United Kingdom
5Oncology IMED Biotech Unit, Roche, Welwyn Garden City, United Kingdom
6Roche Innovation Center Zürich, Roche Pharma Research and Early Development, Zürich, Switzerland
7Roche Innovation Center Munich, Roche Pharma Research and Early Development, Munich, Germany
8Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn, United Kingdom
9Roche Innovation Center Basel,, Roche Pharma Research and Early Development, Basel, Switzerland
10Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland
11Roche Innovation Center Welwyn, Roche Ltd, Welwyn, United Kingdom
12Roche Innovation Center Welwyn, Roche Pharama Research and Early Development, Welwyn, United Kingdom
13A4P Consulting Ltd., Sandwich, United Kingdom
14Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
15Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany
16Department of Hematology, University Lille, CHU Lille, EA 7365 - GRITA - Groupe de Recherche sur les forms Injectables et les Technologies Associées, Lille, France
17Department of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark

Haorui Shen, MD, PhD1*, Jia-Zhu Wu, MD, PhD1*, Jin-Hua Liang, MD, PhD1*, Hua Yin, MD, PhD1*, Li Wang2*, Jianyong Li, MD3 and Wei Xu2

1Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China, Nanjing, China
2Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
3Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Marcus Geer, MD1, Salena Kasha, A.A.2*, David Frame, PharmD3* and Monalisa Ghosh, MD4

1Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI
2Dept of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI
3University of Michigan, Ann Arbor, MI
4Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI

Luis Juarez-Salcedo, MD1*, Nicole Ianniello, PharmD2*, Emily Coughlin, MPH3*, Julio C. Chavez, MD4, Jose Sandoval-Sus, MD5, Samir Dalia, MD6 and Rahul Mhaskar, MD, MPH, PhD3*

1Hospital Universitario La Princesa, Madrid, Madrid, Spain
2Florida Cancer Specialists & Research Institute, Weston, FL
3University of South Florida, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Malignant Hematology and Cellular Therapy at Memorial Healthcare System, Moffitt Cancer Center, Pembroke Pines, FL
6Mercy Clinic, Joplin, MO

Mitchell S. Cairo, MD1, Mark A. Rocco, PhD2*, John Bernard, MD2*, Satya R. Siddani, PhD3*, Apurvasena Parikh, PhD2*, Brian Elliott, MD4 and Birgit Burkhardt, MD, PhD5*

1New York Medical College, Valhalla, NY
2AbbVie, South San Francisco, CA
3AbbVie Inc., North Chicago, IL
4Genmab, Princeton, NJ
5University Hospital Münster, Münster, Germany

Wern Lynn Ng1*, Allison M. Bock, MD2, Iuliia Kovalenko, MD1, Yijin Wert3*, Lay She Ng4*, Yucai Wang, MD, PhD5 and Grzegorz S. Nowakowski, MD2

1UPMC Harrisburg, Harrisburg, PA
2Division of Hematology, Mayo Clinic, Rochester, MN
3UPMC Harrisburg, Harrisburg
4Royal College of Surgeons in Ireland and University College Dublin Malaysia Campus (RUMC), Penang, Malaysia
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

Kamila Polgarova1*, Andrea Janíková, assoc. prof., MD, PhD2*, David Belada, assoc. prof., MD, PhD3*, Vit Prochazka, Prof., MD, PhD4*, Juraj Ďuraš, MD5*, Heidi Móciková, MD, PhD6*, Kateřina Steinerová, MD7*, Vít Campr, MD8*, Petra Blahovcová, Mgr9*, David Zogala, MD, PhD10*, Václav Ptáčník, MD10* and Marek Trneny, MD11

11st Department of Internal Medicine - Hematology, First Medical Faculty, Charles University and General University Hospital, Prague, Prague, Czech Republic
2Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
3Fourth Department of Internal Medicine – Hematology, Charles University and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
4Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
5Department of Hemato-Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic
6Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE, Czech Republic
7Department of Haemato-Oncology, Faculty of Medicine, Charles University and University Hospital Pilsen, Pilsen, Czech Republic
8Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
9Data Centre, Czech Lymphoma Study Group, Prague, Czech Republic
10Departement of Nuclear Medicine, Charles University and General Hospital, Prague, Czech Republic
111st Department of Internal Medicine - Hematology, General Hospital, Charles University, Prague, Czech Republic

Megan Melody, MD, MS1, Frederique St. Pierre, MD1*, Irene Helenowski, PhD1*, William B Pearse, MD2, Chetan Vakkalagadda, MD1*, Joseph R. Leventhal, MD, PhD3*, Bing Ho, MD, MPH3*, John Friedewald, MD3*, Daniel Ganger, MD4*, Jane N. Winter, MD1, Leo I. Gordon, MD1, Adam Yuh Lin, MD, PhD1, Reem Karmali, MD, MSc1, Shuo Ma, MD1, Barbara Pro, MD5 and Jonathan Moreira, MD1

1Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Hematology and Oncology, University of California, San Diego, La Jolla, CA
3Northwestern University Medical Center, Comprehensive Transplant Center, Chicago, IL
4Northwestern University Medical Center, Northwestern Medicine Digestive Health Center, Chicago, IL
5Department of Hematology and Oncology, Columbia University Medical Center, New York, NY

Alexandre Willaume, MD1*, Mourtaza Karimdjee, MD2*, Sandy Amorim, MD3*, Benjamin Carpentier, MD4*, Benedicte Hivert, MD5*, Emmanuelle Bourgeois-Petit, MD6*, Pierre Gosset, MD7*, Alban Bailliez, MD, PhD8* and Laurent Pascal, MD, PhD9*

1Université Catholique de Lille, Hôpital Saint Vincent de Paul, Lille, FRA
2Humanitep, Groupement des Hôpitaux Catholique de Lille, LOMME, France
3Hématologie clinique, Hôpital Saint Vincent de Paul, Lille, France
4Hopital Saint Vincent, GHICL, Lille, FRA
5Groupement des Hopitaux Institut Catholique de Lille, Lille, France
6Hematology, Hôpital Saint Vincent de Paul, Lille Cedex, FRA
7Hôpital Saint Vincent de Paul, Laboratoire d'Anatomo-Pathologie, Groupement des Hôpitaux Catholique de Lille, LILLE, France
8Hôpital Saint Philibert, Humanitep, Groupement des Hôpitaux Catholique de Lille, LOMME, France
9Université Catholique de Lille, Hopital Saint Vincent de Paul, Lille, FRA

Azza Ali Fahmy Ayad, MSc1*, Reham Abdelaziz Khedr, MD2,3, Asmaa Mohammed Hamoda, MD, PhD, MSc4*, Tamer Diab5*, Nahla Elnabarawy6*, Elhamy Rifky7*, Leslie E. Lehmann, MD8,9,10 and Alaa M. Elhaddad, MD11,12

1Pediatric Oncology, Children's cancer Hospital Egypt 57357, Cairo, EGY
2Pediatric oncology, Chlidren’s Cancer Hospital Egypt 57357, Cairo, Egypt
3Pediatric oncology, National Cancer Institute - Cairo university, Cairo, Egypt
4National cancer Institute- Cairo University / CCHE57357, Cairo, EGY
5Psychology department, Children's Cancer hospital Egypt, cairo, Egypt
6Children's cancer hospital Egypt 57357, cairo, Egypt
7Children's cancer hospital 57357Egypt, cairo, Egypt
8Department of Pediatrics, Harvard Medical School, Boston, MA
9Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA
10Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA
11Department of Pediatric Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Cairo University, Cairo, Egypt
12Department of Pediatric Oncology and Stem Cell Transplantation Unit, Children Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt

Narendranath Epperla, MD, MS1, Adam Zayac, MD2, Daniel J. Landsburg, MD3, Mitchell Hughes, PharmD3*, Allison M. Bock, MD4, Grzegorz S. Nowakowski, MD4, Emily C. Ayers, MD5, Mark Girton, MD6*, Marie Hu7*, Amy Beckman, MD7*, Shaoying Li8*, L. Jeffrey Medeiros, MD9, Julie E. Chang, MD10, Adam Stepanovic, MD10*, Habibe Kurt, MD11*, Jose Sandoval-Sus, MD12, M. Ali Ansari-Lari, MD13*, Shalin K. Kothari, MD14, Anna Kress, MD15, Mina L Xu, MD16*, Pallawi Torka, MD17, Suchitra Sundaram, MD18*, Stephen D Smith, MD19*, Kikkeri N Naresh, MD, MBBS20, Yasmin Karimi, MD21*, David A. Bond, MD, BS22, Umar Farooq, MD23, Mahak Saad, MD23*, Andrew Matthew Evens, DO, MBA, MMSc24, Karan Pandya, MD25*, Seema G Naik, MD26*, Manali Kamdar27*, Bradley M. Haverkos, MD, MS, MPH28, Reem Karmali, MD, MSc29, Timothy S Oh, MD30*, Julie M. Vose, MD, MBA31, Heather Nutsch31*, Paul Rubinstein, MD32*, Amina Chaudhry, MD32 and Adam J. Olszewski, MD33

1The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
2Department of Medicine, Englewood Health Physician Network, Englewood, NJ
3Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
4Division of Hematology, Mayo Clinic, Rochester, MN
5University of Virginia, Charlottesville, VA
6Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA
7Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
8Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
11Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, RI
12H Lee Moffitt Cancer Center at Memorial Cancer Institute, Ft Lauderdale, FL
13Department of Pathology, Hematopathology, Memorial Health System-Moffitt Cancer Center, Hollywood, FL
14Center of Molecular and Cellular Oncology and Department of Internal Medicine, Section of Hematology,, Yale University School of Medicine, New Haven, CT
15Yale University School of Medicine, New Haven, CT
16Yale University School of Medicine and Yale Cancer Center, New Haven, CT
17Roswell Park Comprehensive Cancer Center, Buffalo, NY
18Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
19Division of Medical Oncology, Fred Hutchinson Cancer Center/University of Washington, Seattle, WA
20Department of Pathology, University of Washington, Seattle, WA
21Division of Hematology-Oncology, University of Michigan Health, Ann Arbor, MI
22Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
23Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
24Rutgers Cancer Institute of New Jersey, Warren, NJ
25Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
26Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
27University of Colorado School of Medicine, Denver, CO
28Division of Hematology, University of Colorado, Aurora, CO
29Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
30Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
31University of Nebraska Medical Center, Omaha, NE
32Department of Hematology-Oncology, University of Illinois-Chicago, Chicago, IL
33Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI

Tomoyo Kubo, MD1*, Yoshimitsu Shimomura, MD1,2*, Hayato Maruoka, MHS3*, Yuya Nagai, MD, PhD1*, Tadakazu Kondo, MD, PhD1 and Takayuki Ishikawa1

1Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
2Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan
3Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan

Yurou Chu1*, Yingyue Liu1*, Xiaosheng Fang, MD, PhD2*, Yujie Jiang, MD2, Mei Ding, MD2*, Xueling Ge, MD2*, Dai Yuan2*, Kang Lu, PhD2*, Peipei Li, PhD2*, Ying Li, MD2*, Hongzhi Xu, MD2*, Juan Fan2*, Xiangxiang Zhou, PhD1,2* and Xin Wang1,2

1Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
2Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Sarah L Beverstock1*, Gabrielle Clark1*, Nicole Haggarty1*, Clare Brown1* and Victoria Louise Campbell, BSc, FRCPath, MBBS, MRCP2*

1Western General Hospital, Edinburgh, United Kingdom
2Western General Hospital, Edinburgh, GBR

*signifies non-member of ASH